See also this year's filing and all EDGAR filings for this company.
PDF Report 0001685071_2019_Dova_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001685071')"} |
Graph
Absolute values for 0001685071, Dova Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 111,807,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 362,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 19,497,000 |
| 5 | LiabilitiesNoncurrent | 2,373,000 |
| 6 | remainder_Liabilities | 13,941,000 |
| 7 | CostOfGoodsAndServicesSold | 1,180,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 61,921,000 |
| 9 | ResearchAndDevelopmentExpense | 18,304,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 10,355,000 |
| 12 | remainder_NetIncome | -1,232,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 112,169,000 |
| 1 | Liabilities | 35,811,000 |
| 2 | Expenses | 81,405,000 |
| 3 | Revenues | 10,355,000 |
| 4 | StockholdersEquity | 76,358,000 |
| 5 | NetIncome | -72,282,000 |
| 6 | ComprehensiveNetIncome | -72,282,000 |
| 7 | BaseVar | 120,486,000 |
| 8 | EconomicCapitalRatio | 0.798 |
Edgar->Model Mapping
Feature Distribution
Change over Time
